生命科学资讯

Moderna accuses FDA of shifting standard as agency refuses flu shot review

Isomorphic claims major advance with new AI drug design engine

ILiAD raises $115M round to advance whooping cough vaccine

AbbVie, AstraZeneca lose appeal in Louisiana 340B contract pharmacy fight

NIH stops low-dose Xarelto arm of large stroke study due to safety concerns

Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study

Financings for Feb. 10, 2026

In the clinic for Feb. 10, 2026

Other news to note for Feb. 10, 2026

Regulatory actions for Feb. 10, 2026

Pharma company, execs charged with securities fraud

Is AstraZeneca on track to meet its $80B revenue target?

FDA rejects Regenxbio treatment in another blow to gene therapy

Waters Corporation (WAT): Guggenheim Reiterates 'Buy' Rating wit - GuruFocus

The fallout from Novo vs. Hims

Planetary microbiome structure and generalist-driven gene flow across disparate habitats

Kailera, Hengrui tout up to 12% weight loss in midstage study for obesity pill

Evommune's Dupixent-like phase 2 eczema data drive 75% stock rally

Merck teams up with British medtech to boost vaginal therapeutics delivery system

AstraZeneca reveals oral GLP-1 scored phase 2 wins but holds back weight loss data